The rapid global spread of carbapenem-resistant Enterobacteriaceae (CRE) poses an urgent threat to public health. More than 250 class D -lactamases (OXAs) have been described in recent years, with variations in hydrolytic activity for -lactams. The plasmid-borne OXA-48 -lactamase and its variants are identified only sporadically in the United States but are common in Europe. Recognition of these OXA-48-like carbapenemases is vital in order to control their dissemination. We developed a realtime PCR assay based on high-resolution melt analysis, using bla OXA-48-like -specific primers coupled with an unlabeled 3=-phosphorylated oligonucleotide probe (LunaProbe) homologous to OXA-48-like carbapenemase genes. The assay was validated using genomic DNA from 48 clinical isolates carrying a variety of carbapenemase genes, including bla KPC , bla SME , bla IMP , bla NDM-1 , bla VIM , bla OXA-48 , bla OXA-162 , bla OXA-181 , bla OXA-204 , bla OXA-244 , bla OXA-245 , and bla OXA-232 . Our assay identified the presence of bla OXA-48-like -lactamase genes and clearly distinguished between bla OXA-48 and its variants in control strains, including between bla OXA-181 and bla OXA-232 , which differ by only a single base pair in the assay target region. This approach has potential for use in epidemiological investigations and continuous surveillance to help control the spread of CRE strains producing OXA-48-like enzymes.